Utibron Neohaler
Utibron Neohaler (indacaterol / glycopyrrolate) is a combination inhaler used for the long-term treatment of chronic obstructive pulmonary disease (COPD). It's no longer available in the United States, because it was discontinued.
What is Utibron Neohaler (indacaterol / glycopyrrolate)?
What is Utibron Neohaler (indacaterol / glycopyrrolate) used for?
- Long-term treatment of COPD
Drug facts
Common questions about Utibron Neohaler (indacaterol / glycopyrrolate)
Utibron Neohaler (indacaterol / glycopyrrolate) is made up of two medications that work to treat COPD. Indacaterol is a long-acting beta agonist (LABA). Glycopyrrolate is a long-acting muscarinic antagonist (LAMA), which is also known as an anticholinergic. They both work by relaxing the muscles in your lungs to open up your airways and make it easier for you to breathe.
No, Utibron Neohaler (indacaterol / glycopyrrolate) has been discontinued and is no longer available in the United States. It's not clear why the medication was discontinued.
There are several inhalers on the market that are approved and commonly used for COPD. Examples of available combination inhalers like Utibron Neohaler (indacaterol / glycopyrrolate) include Anoro Ellipta (umeclidinium / vilanterol), Stiolto Respimat (tiotropium / olodaterol), and Duaklir Pressair (aclidinium / formoterol). Review this guide to COPD inhalers and talk to your provider to see which is best for you.
How to save using GoodRx
Utibron Neohaler (indacaterol / glycopyrrolate) dosage
Typical dosage for Utibron Neohaler (indacaterol / glycopyrrolate)
What are alternatives to Utibron Neohaler (indacaterol / glycopyrrolate)?
